Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Gastrointestinal function" refers to the collective physiological processes carried out by the digestive tract, including motility, secretion, digestion, absorption of nutrients and water, immune surveillance within the gut mucosa, and hormone-mediated regulation. These functions are coordinated by complex interactions among various cell types—such as enteric neurons[4], smooth muscle cells[4], epithelial cells, immune cells—and regulated by numerous signaling molecules and pathways. While many drugs act to modulate aspects of gastrointestinal physiology (e.g., promotility agents targeting enteric neurons or smooth muscle contraction[4]), "gastrointestinal function" itself is not a single molecule or receptor but rather an umbrella term for multiple integrated biological activities. Therefore, it does not correspond to a canonical therapeutic target such as an enzyme or receptor. There is something incorrect with using "Gastrointestinal function" as a drug target entry because it lacks specificity—it does not refer to any particular molecule or defined pharmacological entity suitable for structured data extraction about drug-target interactions. Instead, research and therapy focus on specific molecular targets within pathways that regulate GI functions—such as neurotransmitter receptors in enteric neurons[4], transporters like GLUT1/LAT1 in neuroendocrine tumors[6], hormone receptors (e.g., somatostatin receptor), growth factor receptors (e.g., VEGF/FGF/CSF1R)[6], and others. Regarding biomarkers, there is no single biomarker; many are possible depending on the specific aspect of GI function or disease context[5][6]. Safety concerns are not applicable as this is not a discrete molecular target. In summary: "Gastrointestinal function" is too broad and non-specific to serve as a canonical therapeutic target; instead, individual molecules involved in regulating these functions are considered valid targets for drug development and clinical intervention[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal function.